Načítá se...

Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria

Phenylketonuria (PKU) is a metabolic disorder, in which loss of phenylalanine hydroxylase activity results in neurotoxic levels of phenylalanine. We used the Pah(enu2/enu2) PKU mouse model in short- and long-term studies of enzyme substitution therapy with PEGylated phenylalanine ammonia lyase (PEG-...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sarkissian, Christineh N., Gámez, Alejandra, Wang, Lin, Charbonneau, Marilyse, Fitzpatrick, Paul, Lemontt, Jeffrey F., Zhao, Bin, Vellard, Michael, Bell, Sean M., Henschell, Carroll, Lambert, Amy, Tsuruda, Laurie, Stevens, Raymond C., Scriver, Charles R.
Médium: Artigo
Jazyk:Inglês
Vydáno: National Academy of Sciences 2008
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2634911/
https://ncbi.nlm.nih.gov/pubmed/19095795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0808421105
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!